-
Founded in:
1981-12-14 -
Country:
China -
Address:
No. 2, Haixin Road, Haiyu Town, Changshu City, Jiangsu Province -
Tax NO.:
91320581137714223E -
Registered Funds:
129 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Clindamycin phosphate |
After absorption, it can be hydrolyzed into clindamycin to exert antibacterial effects, especially against Propionibacterium acnes. It can also reduce fatty acids on the skin surface, which is beneficial for the treatment of acne.
More
After absorption, it can be hydrolyzed into clindamycin to exert antibacterial effects, especially against Propionibacterium acnes. It can also reduce fatty acids on the skin surface, which is beneficial for the treatment of acne. |
24729-96-2 | 33 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Clindamycin phosphate |
After absorption, it can be hydrolyzed into clindamycin to exert antibacterial effects, especially against Propionibacterium acnes. It can also reduce fatty acids on the skin surface, which is beneficial for the treatment of acne.
More
After absorption, it can be hydrolyzed into clindamycin to exert antibacterial effects, especially against Propionibacterium acnes. It can also reduce fatty acids on the skin surface, which is beneficial for the treatment of acne. |
24729-96-2 | 33 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Venlafaxine hydrochloride |
This product mainly exerts its antidepressant effect by inhibiting the reuptake of serotonin and norepinephrine by the central nervous system, thereby increasing the concentration of these two monoamine transmitters in the synaptic cleft.
More
This product mainly exerts its antidepressant effect by inhibiting the reuptake of serotonin and norepinephrine by the central nervous system, thereby increasing the concentration of these two monoamine transmitters in the synaptic cleft. |
99300-78-4 | 84 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Ofloxacin |
The experiment was not conducted and there is no reliable reference
More
The experiment was not conducted and there is no reliable reference |
82419-36-1 | 30 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| (S)-(+)-Ibuprofen |
By inhibiting the synthesis of prostaglandins or other inflammatory mediators, it exhibits anti-inflammatory, analgesic and antipyretic effects. It is more potent than ibuprofen and takes effect more quickly.
More
By inhibiting the synthesis of prostaglandins or other inflammatory mediators, it exhibits anti-inflammatory, analgesic and antipyretic effects. It is more potent than ibuprofen and takes effect more quickly. |
51146-56-6 | 21 |